Scientists expect cure for cancer in 1 year

A team of Israeli scientists believes it may have found the cure of all cures to finally end cancer.

"We believe we will offer in a year's time a complete cure for cancer", Mr Aridor told The Jerusalem Post.

AEBi CEO Dr. Ilan Morad said by using this anti-cancer cocktail, "we made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer".

It's not clear how the company could promise to offer a cancer cure within 12 months if clinical trials will take years.

The company equates the MuTaTo concept to the drug cocktail that helped change AIDS from being an automatic death sentence to a chronic, but manageable, disease.

Even hints at a cure for cancer are big news - according to statistics, every sixth death is a result of cancer, making it the second leading cause of death in the world after cardiovascular diseases.

The team has already conducted successful tests on mice using their breakthrough drug, which "inhibited human cancer cell growth and had no effect at all on healthy mice cells".

Dr. Len Lichtenfeld, chief medical officer of the American Cancer Society, said in a blog Tuesday that "it goes without saying, we all share the aspirational hope that they are correct".

Morad said MuTaTo is also strong enough to both destroy stem cells and penetrate where other drugs can not reach.

"The probability of having multiple mutations that would modify all the targeted receptors decreases dramatically with the number of targets used", Morad continued. "Our solution will be both generic and personal".

An Israeli biotech company said preliminary research on mice gives it hope of developing a cancer cure "within a year's time" - but it still has years of testing ahead of it before it could get US approval - even if it works for humans. "Not even cancer can mutate three receptors at the same time".

But, according to Neel, "More likely, this claim is yet another in a long line of spurious, irresponsible and ultimately cruel false promises for cancer patients". The company will soon begin clinical trials that could be completed within "a few years" and would make the treatment available in specific cases, the Post reports.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.